BridgeMD
Tests treatment safety and results for Sciatica
Official title Immediate and 1-week Efficacy of a Single Session of Sciatic Nerve Electrical Stimulation in the Management of Low-back Related Leg Pain
ClinicalTrials.gov ID: NCT07377357
What this study is testing
- What it's testing
- This clinical study focuses on people who experience long-term low-back related leg pain (commonly called sciatica). This type of pain is often associated with nerve irritation or compression in the lower spine and can cause symptoms like shooting or burning pain, tingling, numbness, or weakness in the leg.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Neuropathic-like LBRLP (sciatica).
- S-LANSS score ≥ 12 points.
- LBRLP lasting more than 6 months.
- Age between 18 and 70 years.
- LBRLP in the past 4 weeks has been severe enough to limit usual activities or change daily routines for more than 1 day.
You likely can't join if
- Acute injury or recent major trauma history.
- Relevant painful conditions of the hip joint or pelvic/sacroiliac region.
- Symptoms compatible with cauda equina syndrome (loss of bladder/bowel control, sexual dysfunction, paralysis of lower limbs, etc.).
- Previous surgery on the spine, pelvis or hip.
- Prior treatment with anesthetic or anti-inflammatory blocks or with radiofrequency (facet, sacroiliac, radicular, epidural, etc.) in the past two...
- Any neurological or systemic disease that could limit participation in the study.
See the full eligibility criteria
- Neuropathic-like LBRLP (sciatica).
- S-LANSS score ≥ 12 points.
- LBRLP lasting more than 6 months.
- Age between 18 and 70 years.
- LBRLP in the past 4 weeks has been severe enough to limit usual activities or change daily routines for more than 1 day.
- At least one period of 6 months to 1 year during which the participant did not go a full month without LBRLP.
- LBRLP intensity of at least 3/10 on the NPRS.
- Ability to provide informed consent.
- Acute injury or recent major trauma history.
- Relevant painful conditions of the hip joint or pelvic/sacroiliac region.
- Symptoms compatible with cauda equina syndrome (loss of bladder/bowel control, sexual dysfunction, paralysis of lower limbs, etc.).
- Previous surgery on the spine, pelvis or hip.
- Prior treatment with anesthetic or anti-inflammatory blocks or with radiofrequency (facet, sacroiliac, radicular, epidural, etc.) in the past two years.
- Any neurological or systemic disease that could limit participation in the study.
- Inability to communicate in Spanish or understand study instructions and content.
- General contraindications for invasive physiotherapy and electrotherapy techniques.
The study team makes the final eligibility decision.
Where it's taking place
- Madrid, Madrid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madrid, Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.